Corcept accused in California of stifling Teva’s generic launch
A group of health insurers has filed a lawsuit against Corcept Therapeutics (NASDAQ:CORT) in California, accusing the rare ...
Drug Store News3h
Axsome, Teva settle litigation over Auvelity
Axsome will grant Teva a license to sell its generic version of Auvelity beginning on or after March 31, 2039, if pediatric ...
Kauppalehti6h
Putting Patients First: Why Europe Must Act to Protect Access To Medicines
A diversified supply of critical generic medicines from multiple manufacturers is required to ensure that healthcare systems can meet the needs of their patients. The research shows that for most ...
Billionaire Stanley Druckenmiller Dumped Duquesne's Entire Stake in Broadcom and Bought One of Wall Street's Hottest Drug Stocks Hand Over Fist
Duquesne Family Office's billionaire chief shed a trillion-dollar artificial intelligence (AI) stock in favor of a historically cheap drugmaker that's more than doubled in less than two years.
Bausch Health projects $4.95B-$5.1B revenue for 2025 with focus on growth and innovation
Q4 2024 Management View CEO Thomas Appio highlighted seven consecutive quarters of revenue and adjusted EBITDA growth, driven by strong execution and a focus on patient-centered outcomes. The company ...